These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2887173)

  • 1. Pharmacodynamics of the new H1-antagonist 3-amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride in volunteers.
    Adamus WS; Oldigs-Kerber J; Lohmann H
    Arzneimittelforschung; 1987 May; 37(5):569-72. PubMed ID: 2887173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers.
    Schilling JC; Adamus WS; Kuthan H
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):493-7. PubMed ID: 1982280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
    Tasaka K; Kamei C; Nakamura S
    Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
    Misawa M; Kanai Y
    Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihistamine activity and central effects of WAL 801 CL in man.
    Adamus WS; Oldigs-Kerber J; Lohmann HF
    Eur J Clin Pharmacol; 1987; 33(4):381-5. PubMed ID: 2894993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
    García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
    Barbanoj MJ; García-Gea C; Morte A; Izquierdo I; Pérez I; Jané F
    Neuropsychobiology; 2004; 50(4):311-21. PubMed ID: 15539863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch ; Shamsi Z
    Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
    Van Neste D; Rihoux JP
    Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacological properties of optical isomers and a racemic mixture of epinastine.
    Tasaka K; Kamei C; Izushi K; Tsujimoto S; Yoshida T
    Arzneimittelforschung; 1991 Mar; 41(3):219-23. PubMed ID: 1714277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
    Leroy T; van Neste D
    Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ranitidine alone and in combination with chlorpheniramine on histamine-induced wheal and flare and psychomotor performance.
    Khosla PP; Saha N; Koul A; Chakrabarti A; Sankaranarayanan A; Sharma PL
    Indian J Physiol Pharmacol; 1993 Apr; 37(2):132-4. PubMed ID: 8251028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
    Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
    Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
    Denham KJ; Boutsiouki P; Clough GF; Church MK
    Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The time course of action of three differing doses of noberastine, a novel H1-receptor antagonist, on histamine-induced skin wheals and the relationship to plasma drug concentrations in normal human volunteers.
    Wood-Baker R; Emanuel MB; Hutchinson K; Howarth PH
    Br J Clin Pharmacol; 1993 Feb; 35(2):166-70. PubMed ID: 8095149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.